Clincosm LogoSign in Get a demo

superficial bladder cancer

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Superficial Bladder Cancer Trial in United States (ADSTILADRIN)

Active, not recruiting
Has Results
  • Superficial Bladder Cancer
  • ADSTILADRIN
  • Gilbert, Arizona
  • +33 more
Dec 2, 2022

Bladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer Trial in Ankara (Intravesical Solution)

Recruiting
  • Bladder Cancer
  • +3 more
  • Intravesical Solution
  • Ankara, Altindag, Turkey
    Ankara Training and Research Hospital
Jul 4, 2022

Superficial Bladder Cancer Trial in United States (EG-70)

Recruiting
  • Superficial Bladder Cancer
  • Tucson, Arizona
  • +7 more
May 11, 2022

Superficial Bladder Cancer Trial in Egypt, Germany (abnobaVISCUM 900, Mitomycin C)

Recruiting
  • Superficial Bladder Cancer
  • abnobaVISCUM 900
  • Mitomycin C
  • Giza, Egypt
  • +18 more
Apr 25, 2022

Superficial Bladder Cancer Trial in Worldwide

Completed
  • Superficial Bladder Cancer
    • Kansas City, Kansas
    • +18 more
    Oct 11, 2021

    Superficial Bladder Cancer, Bladder Cancer Trial in Netherlands (Metformin)

    Recruiting
    • Superficial Bladder Cancer
    • Bladder Cancer
    • Nijmegen, Gelderland, Netherlands
    • +3 more
    Jan 15, 2021

    Superficial Bladder Cancer Trial in Israel, United States (BC-819/PEI)

    Completed
    Has Results
    • Superficial Bladder Cancer
    • BC-819/PEI
    • Phoenix, Arizona
    • +5 more
    Apr 8, 2019

    Superficial Bladder Cancer Trial (INSTILADRIN)

    Completed
    Has Results
    • Superficial Bladder Cancer
    • (no location specified)
    Jun 23, 2017

    Predicting Outcome of Non-muscle Invasive Bladder Cancer (NMIBC)

    Unknown status
    • Oncology
    • +5 more
      • Mansora, Aldakahlia, Egypt
        Urology and Nephrology Center
      May 14, 2017

      Transitional Cell Carcinoma of Bladder, Superficial Bladder Cancer Trial in Durham (Hyperthermia System, Mitomycin C)

      Completed
      Has Results
      • Transitional Cell Carcinoma of Bladder
      • Superficial Bladder Cancer
      • Hyperthermia System
      • Mitomycin C
      • Durham, North Carolina
        Duke University Medical Center
      Jun 1, 2015

      Superficial Bladder Cancer Trial in Giza, Essen (abnobaVISCUM Fraxini)

      Completed
      • Superficial Bladder Cancer
      • abnobaVISCUM Fraxini
      • Giza, Egypt
      • +1 more
      May 5, 2015

      Superficial Bladder Cancer, Lower Urinary Tract Symptoms Trial in Rome (Intravesical baobab oil)

      Completed
      • Superficial Bladder Cancer
      • Lower Urinary Tract Symptoms
      • Intravesical baobab oil
      • Rome, Italy
      • +1 more
      Sep 5, 2013

      Superficial Bladder Cancer Trial in Gainesville (Whole bladder laser light treatment as an alternative to radical cystectomy,

      Completed
      • Superficial Bladder Cancer
      • Whole bladder laser light treatment as an alternative to radical cystectomy
      • Photofrin
      • Gainesville, Florida
        Malcom Randall NF/SG Veterans Administration Health System
      Oct 25, 2012

      Superficial Bladder Cancer Trial in Rome (Mitomycin-C 40 mg)

      Completed
      • Superficial Bladder Cancer
      • Mitomycin-C 40 mg
      • Rome, Italy
        Dept. of Surgery, Tor Vergata University
      Oct 3, 2011

      Superficial Bladder Cancer Trial in United States (Chemophase)

      Completed
      • Superficial Bladder Cancer
      • Phoenix, Arizona
      • +4 more
      Feb 5, 2010

      Superficial Bladder Cancer Trial in Israel (Gemcitabine, mitomycin C)

      Completed
      • Superficial Bladder Cancer
      • Beer Sheva, Israel
      • +4 more
      May 16, 2007

      Superficial Bladder Cancer Trial in Sesto Fiorentino (Gemcitabine)

      Completed
      • Superficial Bladder Cancer
      • Sesto Fiorentino, Florence, Italy
        For additional information regarding investigative sites for thi
      Jan 24, 2007